Biopharma must step up for those on the front lines of COVID-19

While not every biotech can develop countermeasures for COVID-19, nearly all can contribute by providing urgently needed resources to protect the clinicians and other essential workers holding the line against catastrophe, and by making their actions public.

Although several life sciences organizations have already rallied donations from their members, the need hasn’t abated. Many clinics worldwide still have nowhere near the supplies needed to treat the onslaught of COVID-19 patients, let alone protect those treating patients with other conditions. ...